| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 73,210 | 58,941 | 50,649 | | Cost of Revenue | 20,437 | 15,065 | 12,012 | | | Gross Profit | 52,773 | 43,876 | 38,637 | | | Operating Expenses | | Research Development | 25,328 | 24,917 | 22,292 | | Selling General and Administrative | 55,357 | 52,658 | 42,448 | | Non Recurring |
-
| 1,206 | 800 | | Others | 1,606 | 1,582 | 1,608 | | | | Total Operating Expenses |
-
| 80,363 | 67,148 | | | | Operating Income or Loss | (29,518) | (36,487) | (28,511) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,327) | (3,916) | 1,105 | | Earnings Before Interest And Taxes | (30,845) | (40,403) | (27,406) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (30,845) | (40,403) | (27,406) | | Income Tax Expense | 752 | 527 | 475 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (31,597) | (40,930) | (27,881) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (31,597) | (40,930) | (27,881) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($31,597) | ($40,930) | ($27,881) |
|
1.48% Nasdaq 
Income Statement
